We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Definitive IMRT for Stage III Thymic Carcinoma: A Brief Report and Literature Review.
- Authors
Dooley, Sarah A.; Anderson, Carryn M.
- Abstract
Introduction: Thymic carcinoma is a rare malignancy often presenting at an advanced stage. Radiation therapy and chemotherapy are often the only treatment options available to physicians. Methods: A 70-year-old man presented with an unresectable stage III thymic tumor and was treated with 45 Gy in 25 fractions followed by a boost of 21.6 Gy in 12 fractions. He was also treated with bortezomib for multiple myeloma unrelated to his primary malignancy. Results: The patient made a full recovery following the radiation regimen and remained disease free 4 years after the treatment. Conclusion: Exclusive treatment with intensity-modulated radiation therapy provides a viable treatment option for patients presenting with advanced stage thymic carcinoma.
- Subjects
INTENSITY modulated radiotherapy; THYMUS cancer; ENDOCRINE gland cancer; CANCER treatment
- Publication
Frontiers in Oncology, 2016, Vol 6, p1
- ISSN
2234-943X
- Publication type
Article
- DOI
10.3389/fonc.2016.00219